MENU
+Compare
AMRX
Stock ticker: NASDAQ
AS OF
Apr 2, 11:44 AM (EDT)
Price
$8.14
Change
-$0.08 (-0.97%)
Capitalization
1.87B

AMRX Amneal Pharmaceuticals Forecast, Technical & Fundamental Analysis

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U... Show more

AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AMRX with price predictions
Apr 01, 2025

Momentum Indicator for AMRX turns negative, indicating new downward trend

AMRX saw its Momentum Indicator move below the 0 level on March 25, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned negative. In of the 95 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AMRX moved out of overbought territory on March 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for AMRX turned negative on March 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

AMRX moved below its 50-day moving average on March 26, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for AMRX crossed bullishly above the 50-day moving average on February 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRX advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (94.340) is normal, around the industry mean (60.617). P/E Ratio (90.000) is within average values for comparable stocks, (90.174). AMRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.445) is also within normal values, averaging (20.094).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AMRX is expected to report earnings to rise 27.75% to 15 cents per share on May 02

Amneal Pharmaceuticals AMRX Stock Earnings Reports
Q1'25
Est.
$0.15
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.05
The last earnings report on February 28 showed earnings per share of 11 cents, missing the estimate of 15 cents. With 109.45K shares outstanding, the current market capitalization sits at 1.87B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
400 Crossing Boulevard
Phone
+1 908 947-3120
Employees
7700
Web
https://www.amneal.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNEFX58.400.37
+0.64%
American Funds New Economy F3
TSCSX29.150.14
+0.48%
Thrivent Small Cap Stock S
IJSAX13.04N/A
N/A
VY® JPMorgan Small Cap Core Equity A
RTRIX6.96N/A
N/A
Royce Small-Cap Total Return Instl
AGCTX17.63N/A
N/A
American Century Global Small Cap R6

AMRX and Stocks

Correlation & Price change

A.I.dvisor tells us that AMRX and HROW have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRX and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-1.79%
HROW - AMRX
32%
Poorly correlated
-6.09%
CRON - AMRX
32%
Poorly correlated
-1.10%
EBS - AMRX
32%
Poorly correlated
-2.47%
ORGO - AMRX
30%
Poorly correlated
-0.93%
VRNOF - AMRX
30%
Poorly correlated
-1.51%
More